Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

on, as a result of the inclusion of legacy Actavis results.

For the full year 2012, Actavis Pharma net revenue increased 32 percent to $4.45 billion, including product sales of $4.39 billion and other revenue of $61.0 million, primarily due to higher international revenues as a result of the acquisitions of Ascent and the Actavis Group in January 2012 and November 2012, respectively, as well as full year sales of the authorized generic versions of Concerta® and Lipitor® in the U.S., launched in May 2011 and November 2011, respectively. 

Actavis Pharma's adjusted gross margin increased from 46.2 percent in 2011 to 46.6 percent in 2012.Actavis Specialty Brands Segment InformationThree Months EndedTwelve Months EndedDecember 31,December 31, (Unaudited; $ in millions)2012201120122011Product sales

$
2.6$
.1$
411.6$
364.9Other revenue

19.620.870.876.1Net revenue

132.2120.9482.4441.0Operating expenses:Cost of sales

30.626.1115.494.4Research and development

30.76.9146.267.7Selling and marketing

45.346.5175.5168.6Segment contribution

$
25.6$
41.4$
45.3$
.3Segment margin

19.4%34.2%9.4%25.0%Adjusted gross profit (1)

$
.6$
94.8$
367.0$
347.2Adjusted gross margin

76.9%78.4%76.1%78.7%(1)Adjusted gross profit represents net revenue less

adjusted cost of sales and excludes amortization of

acquired intangibles. Pro forma adjustments for the

respective periods include the following: Acquisition and licensing

$
-$
-$
-$
.6Actavis Specialty Brands net revenue increased 9 percent to $132.2 million in the fourth quarter. The increase was due to higher sales of key promoted products including Generess® Fe and Rapaflo® and the addition of Kadian®, which was acquired with the acquisition
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... England Journal of Medicine ( NEJM ) published ... investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in ... lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe ... even in patients who were at high-risk due to ...
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently ... need to urgently address this issue has been emphasized by ... , "Medical device alarm safety in hospitals." According to The ... June 2012, there were 98 alarm related events reported, of ... , 13 resulted in permanent loss of function (13%) ...
(Date:6/19/2013)... YORK , June 19, 2013   Voices ... to finding a cure for brain cancer, today announced ... a grant to support the clinical investigation of Toca ... recurrent high grade glioma brain cancer (Grade 3 or ... developing novel treatments for advanced cancer, with an initial ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... Urges the President to Tell Congress to Fix the Bill ... the Coalition for a Competitive Pharmaceutical Market (CCPM) will launch ... states charging that, during this holiday season, Congress is giving ... by putting brand company profits before patients. The ads ...
... HUNTINGTON BEACH, California and AMSTERDAM, December 17 ,Agendia, ... that,the US Food and Drug Administration (FDA) cleared its ... the only FDA-cleared,breast cancer recurrence test available to patients ... issued four clearances for MammaPrint, covering,all aspects of this ...
Cached Medicine Technology:Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 2Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies' 3FDA Broadens Clearance for Agendia's MammaPrint(R) 2
(Date:6/19/2013)... June 19, 2013 Strict rules ... July 2013, Orriant is launching a new tool ... maintain compliance with regulations. New HHS regulations ... wellness incentives if their employer offers outcome-based, health-contingent, ... been compliant with these standards for nearly a ...
(Date:6/19/2013)... 2013 Citi Bike has come to New York ... David Perna to know for sure how many patients will choose ... they’ll have the option. In fact, he’s happy about anything ... also make it more convenient for them to visit his office ... of Complimentary Alternative Medicine at Back and Body Medical and an ...
(Date:6/19/2013)... medicine and trauma surgery have had a significant ... immediately after major injuries, including burns. Patients ... now are at greatest risk from infections ... sepsis or from inflammation-induced multiorgan failure. ... (MGH) investigators that measures the movement of key ...
(Date:6/19/2013)... results of three important studies have been published in ... of the Congress of Neurological Surgeons . ... Wilkins , a part of Wolters Kluwer Health ... using artificial neural networks (ANNs) may improve the ability ... Another study in the June Neurosurgery supports ...
(Date:6/19/2013)... For those familiar ... name of the 10/90 gap: only 10 per cent of ... 90 per cent of the global disease burden. It was ... initiative (DNDi) came into being in 2003. Coinciding with its ... Foundation Frontiers of Knowledge Award in the Development Cooperation category. ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... YORK, March 21 Haymarket Media Inc. is ... clinicians, The American,Journal of Hematology/Oncology and Oncology Nursing ... previously published by U.S.,HealthCare Communications, of Highland Park, ... a strong oncology presence to the Haymarket,clinical family," ...
... 21 In two weeks, on April,4, 2008, Deerfield Spa ... spa discounts. During the ten-day periods of April 4 to ... days for the price of one,week and receive a $70 ... in between -- from April 13 to 18, 2008 --,Deerfield ...
... increase in personal problems among adolescents with persistent sleeplessness, ... Science Center at Houston say they have completed the ... insomnia on 11 to 17 year olds. More than ... more symptoms of insomnia and almost half of these ...
... March 21 MEDai, Inc., headquartered in,Orlando, FL, ... that,utilize award-winning predictive analytics, has been helping health ... of predictive modeling.,At the upcoming World Research Group ... present a general session and,workshop that helps organizations ...
... recent survey by the Harvard School of Public Health (HSPH) ... Health: Election 2008, finds that Americans are generally split on ... health care system in the world (45% believe the U.S. ... systems; 15% dont know or refused to answer) and that ...
... bacteria in the blood , In developed ... usually occurs through eating contaminated food and causes gastroenteritis. ... 2 and HIV-infected adults usually develop an infection in ... quarter of affected children. There is currently no vaccine ...
Cached Medicine News:Health News:Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications 2Health News:Deerfield Spa, Voted Among 'Best Affordable Spas,' Opens 2008 Season With Discounts, Savings, Gifts, Specials 2Health News:Adolescents with chronic insomnia report 'twofold to fivefold' increase in personal problems 2Health News:MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 3Health News:JCI table of contents: March 20, 2008 2Health News:JCI table of contents: March 20, 2008 3Health News:JCI table of contents: March 20, 2008 4Health News:JCI table of contents: March 20, 2008 5
Store and manage many ECG data from ECG-9020, ECG-9130 or ECG-9320 on the PC. You can search, view, compare, print, and edit analysis results of ECG, and send it to other physicians by e- mail....
... Collagen Glaucoma Drainage Device when used ... has been proven to significantly lower ... complications often associated with penetrating procedures ... As a result, patient outcomes are ...
... Cruise Control is ... STAAR as a filter ... and aspiration tubing that ... the safety and efficiency ...
... Stat Profile Critical Care Xpress is ... gases, electrolytes, chemistry, and hematology with on-board ... one single, compact instrument. Measured tests include ... SO 2 %, hematocrit and hemoglobin, sodium, ...
Medicine Products: